CMV colitis: Difference between revisions

No edit summary
 
Line 12: Line 12:
*[[Nausea/vomiting]]
*[[Nausea/vomiting]]
*Chronic watery [[diarrhea]]
*Chronic watery [[diarrhea]]
*Bloody diarrhea
*[[rectal bleeding|Bloody diarrhea]]
*Worsening symptoms of inflammatory bowel disease
*Worsening symptoms of [[inflammatory bowel disease]]
*Weight loss
*Weight loss
*[[Dehydration]]
*[[Dehydration]]

Latest revision as of 20:03, 29 September 2019

Background

  • CMV is part of the Herpesviridae family
  • 50-80% of the world's population is seropositive for CMV
  • Causes a mild or undetectable infection in immunocompetent hosts
  • Severe systemic illness is found in immunosuppressed hosts

Clinical Features

Differential Diagnosis

Colitis

CMV Diseases

Evaluation

Management

  • Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
  • Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)

Disposition

See Also

External Links

References